Healthcare provider profile · identity verified

William Christopher Snider, DO

Family Practice · HELENA, MT · NPI 1013995141

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	539	153
Lisinopril	Lisinopril	341	95
Losartan Potassium	Losartan Potassium	313	102
Levothyroxine Sodium	Levothyroxine Sodium	303	64
Amlodipine Besylate	Amlodipine Besylate	298	85
Omeprazole	Omeprazole	230	57
Furosemide	Furosemide	194	38
Metformin Hcl Er	Metformin Hcl	175	44
Gabapentin	Gabapentin	164	39
Potassium Chloride	Potassium Chloride	150	30
Tamsulosin Hcl	Tamsulosin Hcl	143	36
Trazodone Hcl	Trazodone Hcl	142	45
Metoprolol Succinate	Metoprolol Succinate	139	44
Fluoxetine Hcl	Fluoxetine Hcl	120	23
Metformin Hcl	Metformin Hcl	113	32
Albuterol Sulfate Hfa	Albuterol Sulfate	110	39
Eliquis	Apixaban	104	21
Hydrochlorothiazide	Hydrochlorothiazide	100	32
Meloxicam	Meloxicam	97	27
Metoprolol Tartrate	Metoprolol Tartrate	96	18
Carvedilol	Carvedilol	95	26
Simvastatin	Simvastatin	95	19
Levetiracetam	Levetiracetam	91	11
Sertraline Hcl	Sertraline Hcl	85	24
Pregabalin	Pregabalin	81	14
Allopurinol	Allopurinol	74	22
Citalopram Hbr	Citalopram Hydrobromide	70	16
Lamotrigine	Lamotrigine	66	suppressed
Duloxetine Hcl	Duloxetine Hcl	58	15
Spironolactone	Spironolactone	58	13
Ventolin Hfa	Albuterol Sulfate	58	12
Pravastatin Sodium	Pravastatin Sodium	56	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	17
Escitalopram Oxalate	Escitalopram Oxalate	47	17
Rosuvastatin Calcium	Rosuvastatin Calcium	44	17
Tramadol Hcl	Tramadol Hcl	41	suppressed
Warfarin Sodium	Warfarin Sodium	41	suppressed
Propranolol Hcl	Propranolol Hcl	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Alendronate Sodium	Alendronate Sodium	37	12
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	12
Finasteride	Finasteride	37	suppressed
Cilostazol	Cilostazol	36	suppressed
Aripiprazole	Aripiprazole	35	11
Ozempic	Semaglutide	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Prazosin Hcl	Prazosin Hcl	32	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	31	11
Donepezil Hcl	Donepezil Hcl	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	11
Symbicort	Budesonide/Formoterol Fumarate	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	11
Baclofen	Baclofen	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Famotidine	Famotidine	25	11
Jardiance	Empagliflozin	25	suppressed
Olanzapine	Olanzapine	24	suppressed
Typhim Vi	Typhoid Vi Polysacch Vaccine	24	23
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Valsartan	Valsartan	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Sulfasalazine	Sulfasalazine	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Atenolol	Atenolol	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Prednisone	Prednisone	20	17
Valacyclovir	Valacyclovir Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Glipizide	Glipizide	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	17	16
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Havrix	Hepatitis A Virus Vaccine/Pf	15	14
Memantine Hcl	Memantine Hcl	15	suppressed
Tivicay	Dolutegravir Sodium	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ipol	Poliomyelitis Vaccine, Killed	14	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	13	12
Calcitriol	Calcitriol	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Levofloxacin	Levofloxacin	13	suppressed
Methimazole	Methimazole	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Twinrix	Hepatitis A And B Vaccine/Pf	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	12	suppressed
Estradiol	Estradiol	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Naproxen	Naproxen	12	suppressed
Torsemide	Torsemide	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error